STOCK TITAN

Option Care Health Announces Secondary Offering of 13,000,000 Shares of Common Stock and Common Stock Repurchase

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
buyback
Rhea-AI Summary

Option Care Health (NASDAQ: OPCH) announced a secondary offering of 13 million shares by an affiliate of Walgreens Boots Alliance, with no proceeds going to the company. Concurrently, Option Care plans to repurchase shares worth approximately $75 million from the selling stockholder, funded by cash on hand. The repurchase is contingent on the closing of the offering, which is underwritten by Goldman Sachs. The company emphasizes its role as the largest independent provider of home infusion services, catering to patients across 50 states.

Positive
  • The concurrent share repurchase may enhance shareholder value by reducing the number of outstanding shares.
  • Repurchasing shares at $75 million indicates management's confidence in the company's future.
Negative
  • The company will not receive any proceeds from the share offering, potentially limiting capital for growth.
  • The secondary offering may lead to short-term dilution of existing shareholders’ equity.

BANNOCKBURN, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell 13,000,000 shares of the Company’s common stock in an underwritten secondary offering. The Company will not receive any proceeds from the offering.

Goldman Sachs & Co. LLC is acting as the sole underwriter for the offering.

In addition, the Company has entered into an agreement to concurrently repurchase a number of shares of common stock from the Selling Stockholder equal to an aggregate purchase price of approximately $75 million at a price per share equal to the price at which the underwriter will purchase the shares from the Selling Stockholder in the offering, net of underwriting discounts and commissions. The concurrent share repurchase will be made under the Company’s share repurchase program and the repurchased shares will be held in treasury. The Company intends to fund the concurrent share repurchase with cash on hand. The closing of the concurrent share repurchase will be conditioned upon the closing of the offering and therefore there can be no assurance that the concurrent share repurchase will be completed. The offering is not conditioned upon the completion of the concurrent share repurchase.

A shelf registration statement on Form S-3 relating to the shares of common stock was filed with, and declared effective by, the Securities and Exchange Commission (the “SEC”). The offering may be made only by means of a free writing prospectus, a prospectus supplement and the accompanying prospectus, which will be filed with the SEC. You may get these documents for free by visiting the SEC’s website at www.sec.gov. Alternatively, copies may be obtained from:

Goldman Sachs & Co. LLC
Attn: Prospectus Department
200 West Street
New York, New York 10282
Tel: 866.471.2526
Email: Prospectus-ny@ny.email.gs.com

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor may there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 7,500 team members including more than 4,500 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates.

Forward-Looking Statements - Safe Harbor

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include statements about the Company’s ability to consummate the offering and the Company’s use of proceeds from the offering.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. For a detailed discussion of the factors that could affect our actual results and financial condition, please refer to the risk factors identified in our SEC reports, including, but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the SEC.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

For Investor Inquiries:
Mike Shapiro, Chief Financial Officer
Option Care Health
312.940.2538
Investor.relations@optioncare.com


FAQ

What is the purpose of the OPCH secondary offering?

The secondary offering aims to sell 13 million shares by a stockholder without any proceeds going to Option Care Health.

How much is Option Care Health repurchasing in shares?

Option Care Health plans to repurchase approximately $75 million in shares concurrently with the secondary offering.

Who is underwriting the OPCH share offering?

Goldman Sachs & Co. LLC is the sole underwriter for the secondary offering.

What is the impact of the share repurchase on OPCH's stock price?

The share repurchase may enhance shareholder value and could positively influence OPCH's stock price by reducing the number of outstanding shares.

Option Care Health, Inc.

NASDAQ:OPCH

OPCH Rankings

OPCH Latest News

OPCH Stock Data

3.82B
169.24M
0.55%
107.39%
2.29%
Medical Care Facilities
Services-home Health Care Services
Link
United States of America
BANNOCKBURN